Celcuity (CELC) Other Operating Expenses (2025)

Celcuity (CELC) reported Other Operating Expenses of $35.2 million for Q2 2025.

Celcuity (CELC) Other Operating Expenses (2025) Analysis & Trends

Celcuity has reported Other Operating Expenses for 1 years, with the latest figure at $35.2 million in Q2 2025.

For the quarter ending Q2 2025, Other Operating Expenses changed N/A year-over-year to $35.2 million; the trailing twelve-month figure through Dec 2025 stood at $35.2 million (changed N/A YoY), and the FY2021 full-year result was -$263.0, changed N/A from the prior year.
Other Operating Expenses for Q2 2025 stood at $35.2 million.
The five-year high for Other Operating Expenses was $35.2 million in Q2 2025, with the low at $35.2 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	Celcuity	4.14 Bn	3.42 Bn	-

Download Data

Date	Value
Jun 30, 2025	35.22 Mn